Farah Champsi
Directeur/Membre du Conseil chez POPULATION HEALTH INVESTMENT CO., INC.
Profil
Farah H.
Champsi is currently a Director at Sanarus Medical, Inc., Alta BioPharma Management III LLC, UCSF Benioff Children's Hospital Oakland, Population Health Investment Co., Inc., and a Trustee at Smith College.
She has formerly served as Chairman at Azelon Pharmaceuticals, Inc., Managing Director & General Partner at Alta Partners Management Co. LP, Director at Chimerix, Inc., Aerovance, Inc., Myocor, Inc., Portola Pharmaceuticals, Inc., Agensys, Inc., InterWest Partners LLC, Excaliard Pharmaceuticals, Inc., Trevena, Inc., Independent Director at Kite Pharma, Inc., and Director at Allakos, Inc. She was also the Head-Global Life Sciences Investment Banking Group at Robertson Stephens & Co. Ms. Champsi has an undergraduate degree from Smith College and an MBA from Stanford Graduate School of Business.
Postes actifs de Farah Champsi
Sociétés | Poste | Début |
---|---|---|
POPULATION HEALTH INVESTMENT CO., INC. | Directeur/Membre du Conseil | - |
UCSF Benioff Children's Hospital Oakland
UCSF Benioff Children's Hospital Oakland Hospital/Nursing ManagementHealth Services UCSF Benioff Children's Hospital Oakland provides healthcare services. It offers child life program, family outreach clinics, hand and microsurgery, parent infant programs, pastoral care, neurosurgery, injury prevention programs and respiratory care services. The company was founded by Bertha Wright in 1912 and is headquartered in Oakland, CA. | Directeur/Membre du Conseil | - |
Alta BioPharma Management III LLC | Directeur/Membre du Conseil | - |
Sanarus Medical, Inc.
Sanarus Medical, Inc. Medical SpecialtiesHealth Technology Part of Sanarus Technologies LLC, Sanarus Medical, Inc. manufactures minimally invasive medical devices. The company is based in Pleasanton, CA. The company was founded in 1999 by Seth A. Stabinsky, Glenn Foy. The CEO is BJ Hardman. Sanarus Medical was acquired by Sanarus Technologies LLC on July 16, 2009. | Directeur/Membre du Conseil | - |
Smith College
Smith College Other Consumer ServicesConsumer Services Smith College opened in 1875 with 14 students. Today, Smith is among the largest women’s colleges in Northampton, MA, with students from 48 states and 72 countries. The college remains strongly committed to the education of women at the undergraduate level, but Smith admits both men and women as graduate students. | Directeur/Membre du Conseil | - |
Anciens postes connus de Farah Champsi
Sociétés | Poste | Fin |
---|---|---|
KITE PHARMA INC | Directeur/Membre du Conseil | 03/10/2017 |
TREVENA, INC. | Directeur/Membre du Conseil | 01/12/2014 |
CHIMERIX, INC. | Directeur/Membre du Conseil | 01/06/2014 |
PORTOLA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/05/2013 |
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Farah Champsi
Smith College | Undergraduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ALLAKOS INC. | Health Technology |
TREVENA, INC. | Health Technology |
CHIMERIX, INC. | Health Technology |
Entreprise privées | 14 |
---|---|
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
Myocor, Inc.
Myocor, Inc. Medical SpecialtiesHealth Technology Myocor, Inc. develops products for the treatment of mitral regurgitation and congestive heart failure. It has two products in clinical trials that are designed to improve the pumping efficiency of the heart and thus improve the quality of life of patients. The company was founded in 1996 by Cyril J. Schweich and Todd Mortier and is headquartered in Maple Grove, MN. | Health Technology |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Aerovance, Inc.
Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Distribution Services |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
Sanarus Medical, Inc.
Sanarus Medical, Inc. Medical SpecialtiesHealth Technology Part of Sanarus Technologies LLC, Sanarus Medical, Inc. manufactures minimally invasive medical devices. The company is based in Pleasanton, CA. The company was founded in 1999 by Seth A. Stabinsky, Glenn Foy. The CEO is BJ Hardman. Sanarus Medical was acquired by Sanarus Technologies LLC on July 16, 2009. | Health Technology |
Alta BioPharma Management III LLC | |
Azelon Pharmaceuticals, Inc.
Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Health Technology |
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Robertson Stephens & Co. | Finance |
UCSF Benioff Children's Hospital Oakland
UCSF Benioff Children's Hospital Oakland Hospital/Nursing ManagementHealth Services UCSF Benioff Children's Hospital Oakland provides healthcare services. It offers child life program, family outreach clinics, hand and microsurgery, parent infant programs, pastoral care, neurosurgery, injury prevention programs and respiratory care services. The company was founded by Bertha Wright in 1912 and is headquartered in Oakland, CA. | Health Services |
InterWest Partners LLC
InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Finance |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Population Health Investment Co., Inc.
Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY. | Finance |